Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- BIAF
- Price
- 1.36
- Stock movement up
- +0.05 (3.82%)
- Company name
- bioAffinity Technologies, Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 6.12M
- Ent value
- 1.09M
- Price/Sales
- 0.90
- Price/Book
- 0.69
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -93.28%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
BIAF does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.90 |
| Price to Book | 0.69 |
| EV to Sales | 0.16 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 4.50M |
| EPS (TTM) | -13.82 |
| FCF per share (TTM) | -7.98 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 6.78M |
| Gross profit (TTM) | 1.62M |
| Operating income (TTM) | -10.38M |
| Net income (TTM) | -14.74M |
| EPS (TTM) | -13.82 |
| EPS (1y forward) | -8.10 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 23.92% |
| Operating margin (TTM) | -153.20% |
| Profit margin (TTM) | -217.50% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 7.67M |
| Net receivables | 448.99K |
| Total current assets | 8.61M |
| Goodwill | 1.40M |
| Intangible assets | 731.39K |
| Property, plant and equipment | 1.90M |
| Total assets | 11.55M |
| Accounts payable | 940.76K |
| Short/Current long term debt | 680.95K |
| Total current liabilities | 2.36M |
| Total liabilities | 2.64M |
| Shareholder's equity | 8.90M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -8.45M |
| Capital expenditures (TTM) | 67.86K |
| Free cash flow (TTM) | -8.51M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -165.57% |
| Return on Assets | -127.65% |
| Return on Invested Capital | -157.77% |
| Cash Return on Invested Capital | -91.14% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.37 |
| Daily high | 1.44 |
| Daily low | 1.33 |
| Daily Volume | 70K |
| All-time high | 211.50 |
| 1y analyst estimate | 6.00 |
| Beta | 2.42 |
| EPS (TTM) | -13.82 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BIAF | S&P500 | |
| Current price drop from All-time high | -99.36% | -0.89% |
| Highest price drop | -99.45% | -19.00% |
| Date of highest drop | 29 Dec 2025 | 8 Apr 2025 |
| Avg drop from high | -93.10% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
6.12M
Marketcap category
Small-cap
Description
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Employees
57
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page